form of epidemic modeling, to support the hypothesis that HCV treatment during imprisonment is a powerful opportunity to reduce HCV transmission in this setting. Aside from the prison-specific benefits explored in Bretana et al.'s paper [4] , other modeling studies show that there are important additional community benefits of prison health interventions, including HCV screening and treatment programs. For example, treating 80% of PWID entering prison with chronic HCV and sentences longer than 16 weeks could reduce HCV incidence among all PWID by 46% in 15 years in Scotland [5] .
More broadly, mounting evidence points to incarceration as a risk factor for acquisition of other infectious disease, such as HIV and hepatitis B virus, fatal overdoses and other negative health outcomes among PWID [1, 2] . Modeling studies have shed light on the complex interplay of the syndemic of overlapping incarceration, drug use and infectious disease. In particular, these studies have assessed the contribution of incarceration to disease and ill health among PWID, as well as the potential prison and community benefits of prison-based health interventions. Models have estimated that incarceration-associated risks could contribute to a substantial fraction of new HCV infections, ranging from 14% in a Ukraine-like scenario (where 52% of PWID have ever been incarcerated) to up to 78% in a Thailand-like scenario (where 80% of PWID have ever been incarcerated) [5, 6] . Similar findings are observed for HIV, where incarceration could contribute 11% of new HIV infections among PWID in Tijuana, Mexico from 2012 to 2030 [7] and 28-55% of new HIV infections among PWID during the next 15 years in Ukraine [8] .
Provision of harm reduction in prison, such as opioid agonist therapy (OAT), can prevent HIVand HCV transmission as well as overdose. Continuity of OAT can also provide important benefits, such as reducing fatal overdose, reincarceration and elevated HIV and HCV acquisition during the high-risk period after release. Modeling based on these findings has shown the substantial benefits that prison OAT could generate in terms of averting infections in the community, with OAT in prison and on release reducing overall endemic HCV incidence by 26% in a Ukraine-like scenario and by up to 98% in a Thailand-like scenario [6] . Similarly, OAT in prison and on release could reduce new HIV infections among all PWID in Ukraine by 20% over 15 years [8] . Further modeling work should evaluate the role of incarceration and prison interventions in syndemics of disease and ill-health experienced by people who use and inject drugs.
Together, these modeling studies provide a reminder that people in prison should receive the same access to health interventions as those in the community. The 2015 United Nations Standard Minimum Rules for the Treatment of Prisoners, known as 'Nelson Mandela Rules', directs prisons to maintain the same standards for health care that exist in the community; furthermore, care should be free of charge and offered without discrimination [9] . Health-care services 'should be organized in close relationship with general public health services and should ensure continuity of treatment and care, including for HIV, tuberculosis and other infectious diseases, as well as drug dependence [9] '. However, in many countries routine HCV screening for PWID is not occurring in prison, and HCV treatment is unavailable or restricted. Similarly, HIV antiretroviral treatment access is limited in many carceral settings. The United Nations recommends OAT and needle and syringe programs (NSPs) in prison as part of the comprehensive package of HIV prevention interventions [10] although, as of 2018, only 10 countries implement NSPs in at least one prison and only 54 countries provide some version of OAT in prison [11] . The dynamic nature of incarceration and frequent entries and exits poses a challenge to ensuring adequate linkage to care and follow-up for a multitude of conditions, but this is not an insurmountable barrier. Moreover, the Nelson Mandela Rules mean that this health-care provision and continuity of care is not just recommended, but mandatory. It is time for us to take action to ensure that these standards are met.
